Hodgkin Lymphoma
News
Brentuximab vedotin sBLA receives priority review
The US Food and Drug Administration (FDA) has accepted for priority review a supplemental biologics license application (sBLA) for brentuximab...
News
Research explains why cisplatin causes hearing loss
Researchers have gained new insight into hearing loss caused by cisplatin. By measuring and mapping cisplatin retention in mouse and human inner...
Conference Coverage
A+AVD improves modified PFS in advanced HL
ATLANTA—Phase 3 trial results suggest one 4-drug combination may be more effective than another as frontline treatment for advanced Hodgkin...
News
Inhibitor exhibits activity against range of lymphomas
Preclinical research suggests the dual PI3K/mTOR inhibitor PQR309 has activity against several types of lymphoma and works well in combination...
News
CCSs have increased risk of hypertension
A study of childhood cancer survivors (CCSs) suggests these individuals have an increased risk of developing hypertension as adults. The CCSs...
Conference Coverage
Young female hematologic cancer survivors have increased infertility risk
SAN ANTONIO – The study tracked infertility diagnoses among hematologic cancer survivors aged 16-34 years.
Conference Coverage
Skills training improves psychosocial outcomes for young cancer patients
Developing skills in stress management, goal setting, positive reframing, and benefit finding led to improved psychosocial outcomes over standard...
News
CCSs more likely to stay at jobs to keep health insurance
Survey results suggest childhood cancer survivors (CCSs) in the US are more likely than individuals without a history of cancer to experience “job...
News
Natural selection opportunities tied to cancer rates
Countries with the lowest opportunities for natural selection have higher cancer rates than countries with the highest opportunities for natural...
News
NCCN completes resource on radiation therapy
The National Comprehensive Cancer Network® (NCCN) has announced the release of the newly completed NCCN Radiation Therapy Compendium™. This...
News
Newer blood cancer drugs may not improve OS, QOL
A study of cancer drugs approved by the European Commission from 2009 to 2013 showed that few hematology drugs were known to provide a benefit in...